Autonomous driving decision-making at unsignalized intersections is highly challenging due to complex dynamic interactions and high conflict risks. To achieve proactive safety control, this paper proposes a deep reinforcement learning (DRL) decision-making framework integrated with a biased attention mechanism. The framework is built upon the Soft Actor-Critic (SAC) algorithm. Its core innovation lies in the use of biased attention to construct a traffic risk predictor. This predictor assesses the long-term risk of collision for a vehicle entering the intersection and transforms this risk into a dense reward signal to guide the SAC agent in making safe and efficient driving decisions. Finally, the simulation results demonstrate that the proposed method effectively improves both traffic efficiency and vehicle safety at the intersection, thereby proving the effectiveness of the intelligent decision-making framework in complex scenarios. The code of our work is available at https://github.com/hank111525/SAC-RWB.

Computer-aided cancer survival risk prediction plays an important role in the timely treatment of patients. This is a challenging weakly supervised ordinal regression task associated with multiple clinical factors involved such as pathological images, genomic data and etc. In this paper, we propose a new training method, multimodal object-level contrast learning, for cancer survival risk prediction. First, we construct contrast learning pairs based on the survival risk relationship among the samples in the training sample set. Then we introduce the object-level contrast learning method to train the survival risk predictor. We further extend it to the multimodal scenario by applying cross-modal constrast. Considering the heterogeneity of pathological images and genomics data, we construct a multimodal survival risk predictor employing attention-based and self-normalizing based nerural network respectively. Finally, the survival risk predictor trained by our proposed method outperforms state-of-the-art methods on two public multimodal cancer datasets for survival risk prediction.